2 results found
Quick Verdict Amidst a disturbing rise in US measles cases, biotech firms are stepping up to develop new treatments, offering a beacon of hope where medical options are currently severely limited. While the scientific
This review analyzes the urgent warning from Brown University's Pandemic Center: the measles resurgence signals systemic public health vulnerabilities, high economic costs, and eroding public trust, prefiguring future disease threats.
